India's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...

The vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...

"Indian citizens and students travelling overseas can now take the precaution dose as required by the guidelines of the destination country...

A study showed that if the booster is the same as the first two doses, it boosts immunity well, but when the booster dose is different, the...

"In order to give the benefit of precaution dose to all eligible beneficiaries in Delhi, the same will be available for 18 to 59 years' age...

Nearly all adults and a significant number of children aged 15 years and above have been fully vaccinated in India. This means they have re...

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for...

"Data shows that in people who have taken Covishield, the protein vaccine Covovax works better as a booster than another dose of Covishield...

Many people are wondering how booster side effects compare to the first two doses, when they can get a booster dose after COVID infection, ...

The official said additional need for vaccination and inclusion of population for vaccination is examined constantly.

For the evening with friend, the actor was filmed playing his guitar.

From January 10 healthcare workers, front line workers and persons aged 60 years and above with co-morbid conditions will be eligible for t...

"Need volunteers for a clinical trial. People who have been administered two doses of Covaxin three to six months ago are eligible to enrol...

Protection against COVID-19 infection wanes over time, which has driven consideration of boosters to protect the most vulnerable and lessen...

The AHPI director general Girdhar Gyani said that they have proposed to the government to utilise the surplus vaccine for booster shots. Th...

The panel also recommended that the FDA include healthcare workers and others at high risk of occupational exposure to the virus that cause...

The experts are awaiting results of two ongoing studies in India that will determine whether a booster dose is needed or not. “As of now, n...